| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |